The Company is a Korea-based company mainly engaged in manufacture of medical equipment. The Company s products mainly consist of electrocardiogram electrodes, which are used for electrocardiogram tests, electrosurgery plates, electrosurgery pencils and transcutaneous electrical nerve stimulators (TENS) electrodes, which are used for providing conductive interface between the TENS generator and the patient's skin. The Company was founded on May 19, 2000 and its shares are listed on KOREA NEW EXCHANGE(KONEX) on December 8, 2016.

Headquarters
151-3, Donghwagongdan-Ro, Munmak-Eup, Wonju Si, Gangwon-Do
Wonju; Gangwon;

Contact Details: Purchase the Bio Protech Inc. report to view the information.

Website: http://www.protechsite.com

Basic Information

Total Employees:

Purchase the Bio Protech Inc. report to view the information.

Outstanding Shares:

Purchase the Bio Protech Inc. report to view the information.

Financial Auditors:

Purchase the Bio Protech Inc. report to view the information.

Incorporation Date:

January 15, 2026

Key Executives

Purchase this report to view the information.

Chief Executive Officer

Subsidiaries

㈜바이오프로테크

Company Performance

Financial values in the chart are available after Bio Protech Inc. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.

Net sales revenue

-7.62%▼

Total operating revenue

-7.52%▼

Operating profit (EBIT)

-70.37%▼

EBITDA

-50.36%▼

Net Profit (Loss) for the Period

N/A

Total Assets

5.07%▲

Total Equity

-1440.76%▼

Operating Profit Margin (ROS)

-2%▼

Net Profit Margin

N/A

Return on Equity (ROE)

N/A

Debt/Equity

26201.41%▲

Quick Ratio

Cash Ratio

0.01%▲

Bio Protech Inc. (South Korea)